Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-17

Clinical Trial Update: Randomized Controlled Trial of Treatment to Optimize Heart Rate Variability for Persistent Post-Concussion Symptoms [Phase 2, Phase 3]

View source ↗

Summary

A randomized controlled trial to optimize heart rate variability for persistent post-concussion symptoms is in Phase 2/3 and currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Virginia Commonwealth University | Conditions: Autonomic Nervous System Disease, Concussive Injury | Phase 2, Phase 3 | Status: RECRUITING